Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Abingdon Health PLC ( (GB:ABDX) ) is now available.
Abingdon Health PLC has successfully established its US-based contract development and manufacturing operations in Madison, Wisconsin, with five projects underway since April 2025. The company is expanding its US facility to enhance high-throughput manufacturing, mirroring its UK operations, which will provide customers with geographic flexibility amid tariff and supply chain uncertainties. This expansion underscores Abingdon Health’s strategic growth in the US market, reinforcing its value proposition of delivering end-to-end diagnostic solutions and strengthening its position in the med-tech industry.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £7.00 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall score is driven by its strong business development activities and promising revenue growth, albeit overshadowed by persistent profitability challenges and valuation concerns. Technical indicators suggest a neutral outlook, while recent corporate events present potential for future growth.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health PLC is a prominent med-tech contract service provider, specializing in rapid diagnostic tests and regulatory services for an international clientele. The company offers comprehensive CDMO expertise, including lateral flow product development, regulatory support, and manufacturing services. With capabilities spanning infectious disease, clinical testing, animal health, and environmental testing, Abingdon Health supports projects from concept to commercial success. Founded in 2008, it operates from York, England, with facilities in Doncaster, England, and Madison, Wisconsin, USA.
Average Trading Volume: 114,764
Technical Sentiment Signal: Sell
Current Market Cap: £10.17M
See more data about ABDX stock on TipRanks’ Stock Analysis page.